Nonprofit · EIN 87-1500208
WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC
Tax-exempt · MADISON, WI 53713
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $633,111 | $361,002 | $272,109 | $2,083,502 | $3,135 | $2,080,367 |
| December 31, 2024 | 990 | $2,050,372 | $404,954 | $1,645,418 | $1,823,568 | $15,310 | $1,808,258 |
| December 31, 2023 | 990 | $633,133 | $711,144 | -$78,011 | $192,955 | $30,115 | $162,840 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $573,009
- Program service revenue
- $1,986
- Investment income
- $58,116
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Other salaries and wages
- $260,058
- Salaries, compensation and benefits (total)
- $307,482
- Professional fundraising fees
- $0
- Legal fees
- $1,680
- Program services (functional)
- $316,907
- Management and general (functional)
- $44,095
Balance sheet and other
- Total assets, start of year
- $1,823,568
- Total assets, end of year
- $2,083,502
- Total liabilities, end of year
- $3,135
- Net assets, end of year
- $2,080,367
- Gross receipts
- $633,111
- Employees
- 3
- Volunteers
- 3
- Year formed
- 2021
- State of legal domicile
- WI
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| GARY A DAHL | PRESIDENT Trustee or director, Officer | 1 | $0 |
| JEROME J JENDRISAK | VP, SEC/TREA Trustee or director, Officer | 1 | $0 |
| KIERAN COE | DIRECTOR Trustee or director | 0.1 | $0 |
990 for the year ended December 31, 2024: 3 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| GARY A DAHL | PRESIDENT Trustee or director, Officer | 1 | $0 |
| JEROME J JENDRISAK | VP, SEC/TREA Trustee or director, Officer | 1 | $0 |
| KIERAN COE | DIRECTOR Trustee or director | 0.1 | $0 |
990 for the year ended December 31, 2023: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| JACOBA SLAGTER-JAGER | HEAD OF MRNA Highest-paid employee | 40 | $175,785 |
| GARY A DAHL | PRESIDENT Trustee or director, Officer | 1 | $0 |
| JEROME J JENDRISAK | VP, SEC/TREA Trustee or director, Officer | 1 | $0 |
| KIERAN COE | DIRECTOR Trustee or director | 1 | $0 |
Address and contacts
- Address (IRS master file)
- 726 POST RD, MADISON, WI 53713-4620
- Principal officer (990 for 2025)
- GARY A DAHL, 726 POST ROAD, MADISON, WI 53713
- Signed the 990
- GARY A DAHL, PRESIDENT
- Phone
- (608) 729-1450
- Return prepared by
- CASCADE CPA
Mission
THE ORGANIZATION'S PRIMARY EXEMPT PURPOSE IS TO ENGAGE IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH A HOSPITAL.
Program accomplishments
- IN 2025, WIICT WORKED AS A COLLABORATOR WITH RESEARCHERS AND CLINICIANS FROM INSTITUTIONS INCLUDING: ST. JUDE'S CHILDREN'S HOSPITAL, NATIONAL INSTITUTE FOR ALLERGY AND INFECTIOUS DISEASE/NATIONAL INSTITUTES OF HEALTH, MASSACHUSETTS GENERAL HOSPITAL AND MASSACHUSETTS GENERAL BRIGHAM. COLLABORATIONS INCLUDED THE PRODUCTION OF RESEARCH-GRADE MRNAS FOR USE IN THE DISCOVERY PROCESS FOR BOTH GENE REPLACEMENT AND GENOME-EDITING-BASED THERAPEUTIC TREATMENTS AS WELL AS ONGOING RESEARCH INTO FUTURE ITERATIONS (NEXT GENERATION) FORMS OF THESE TREATMENTS. WIICT ALSO PRODUCED GMP-GRADE MRNAS FOR USE IN BOTH GENE REPLACEMENT AND GENOME-EDITING-BASED THERAPEUTIC TREATMENTS IN FDA-SANCTIONED CLINICAL TRIALS. ONE EXAMPLE IS THE SUCCESSFUL TREATMENT OF THE FIRST EVER IN HUMAN GENE THERAPY TO TREAT AND CURE X-LINKED HYPER IGM SYNDROME (CD40 LIGAND DEFICIENCY), A SERIOUS IMMUNODEFICIENCY DISEASE.Expenses $316,907 · revenue $1,986
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 87-1500208
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2023
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H99)
- Assets (IRS master file)
- $2,083,502
- Income (IRS master file)
- $633,111
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $633,111 | $361,002 | $2,083,502 | XML |
| 990 | December 2024 | $2,050,372 | $404,954 | $1,823,568 | XML |
| 990 | December 2023 | $633,133 | $711,144 | $192,955 | XML |
| 990 | December 2022 | $500,000 | $292,215 | $265,501 | IRS |
| 990-EZ | December 2021 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 87-1500208).
Questions about WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC
- What is the EIN of WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC?
- The employer identification number (EIN) of WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC is 87-1500208.
- Is WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2023.
- Are donations to WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC?
- The 990 for the year ended December 31, 2025 names GARY A DAHL.
- Who are the officers and directors of WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC?
- The 990 for the year ended December 31, 2025 lists 3 people; 0 received compensation from the organization.
- How much revenue does WISCONSIN INSTITUTE FOR IMMUNE AND CELL THERAPY INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $633,111, expenses of $361,002 and total assets of $2,083,502 at year end.
Other nonprofits in MADISON
- MORGRIDGE INSTITUTE FOUNDATION INC EIN 82-2760376 · last filed 990 for 2025
- SUPERIOR HEALTH QUALITY ALLIANCE INC EIN 83-0900646 · last filed 990 for 2024
- WICELL RESEARCH INSTITUTE INC EIN 39-1972235 · last filed 990 for 2025
- INTERNATIONAL CELL RESEARCH ORGANIZATION EIN 45-6205861 · last filed 990 for 2025
- ISTHMUS PROJECT INC EIN 83-2278676 · last filed 990 for 2025
- PAIN RESEARCH FOUNDATION INC EIN 27-4356522 · last filed 990-N for 2025
- ROCKIN4ALS INC EIN 82-5257084 · last filed 990-N for 2024
- EBONY EYES FOUNDATION INC EIN 86-2586887 · last filed 990-N for 2023